home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  May 24, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 461 active entries


Vinlandsleid 14
Reykjavik, 810

Phone: +354 6647903
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Prokazyme develops enzymes from the natural diversity of various extreme environments specializing in geothermal microbial ecosystems in Iceland through exploitations of the genomes of thermophilic bacteria and bacteriophages. The company has various collaborations with other research-oriented companies and academic institutions, it is active in several research consortia in EU-funded collaborative research projects and is offering academic cooperation agreements for marketing of enzymes developed by the academic partners. Prokazyme mainly sells novel enzymes for research, diagnostics and industrial testing purposes through its website at www.prokazyme.com. The products include enzymes active on polysaccharides, such as laminarinase, rhamnosidases and a thermostable beta-1,6-endoglucanase (pustulanase, used in standard assay for beta-glucan in Baker’s yeast) as well as enzymes active on nucleic acids, such as DNA ligases and polynucleotide kinase, and other specialty enzymes such as a thermostable lysozyme.

Selected Categories:

Product Company   Service Company
- Research
- in vitro
- Laboratory
- Research

Last update of this entry: January 03, 2014

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.